Mindblown: a blog about philosophy.
-
MA10-MA50 Bull Crossover: Vascular Biogenics Ltd (VBLT), Wpcs International Inc (WPCS), Ziopharm Oncology Inc (ZIOP)
NASDAQ: VBLT (Vascular Biogenics Ltd) NASDAQ: VBLT (Vascular Biogenics Ltd) has closed at $9.88, its traded Volume was 6954.59K shares, VBLT opened the Day at $9.2, it made an intraday Low of $8.82, and an intraday High of $11.17. VBLT (Vascular Biogenics Ltd) 52-week High is $17.024, 52-week Low is: $3.09, it has supports at…
-
Stocks Slumped amid Selloff in Commodity Prices
U.S. stocks slumped on Tuesday as a slump in commodity prices reignited festering worries about slowing global growth. At close, the Dow Jones Industrial Average dropped 179.72 points, or 1.09%, to 16,330.47. The S&P 500 slid 24.23 points, or 1.23%, to 1,942.74. The Nasdaq Composite lost 72.23 points, or 1.50%, to 4,756.72. Volkswagen has brought…
-
Stocks Started Sharply Lower
U.S. stocks opened sharply lower on Tuesday as renewed fears about China’s troubling growth contributed to the shunning of risky assets such as stocks. The Dow Jones Industrial Average lately dropped 201.54 points, or 1.22%, to 16,308.65. The S&P 500 fell 25.24 points, or 1.28%, to 1,941.73. The Nasdaq Composite was down 69.88 points, or…
-
Top Buy Stocks: Aeterna Zentaris (AEZS), Canadian Natural Resources (CNQ), E.I. Du Pont De Nemours and Company (DD), Gap Inc (GPS), Vale S.A. (VALE)
NASDAQ: AEZS (Aeterna Zentaris) NASDAQ: AEZS (Aeterna Zentaris) has closed at $0.0801, its traded Volume was 130505K shares, AEZS opened the Day at $0.0949, it made an intraday Low of $0.07, and an intraday High of $0.104. AEZS’s close price is above its Short term MA, short term MA is below mid-term, and below long…
-
MACD Bull Crossover: American Eagle Outfitters (AEO), Atmel Corp (ATML), Paypal Holdings Inc (PYPL), Reynolds American Inc (RAI), Suncor Energy Inc (SU)
NYSE: AEO (American Eagle Outfitters) NYSE: AEO (American Eagle Outfitters) has closed at $16.51, its traded Volume was 8675.19K shares, AEO opened the Day at $16.18, it made an intraday Low of $16.18, and an intraday High of $16.75. AEO (American Eagle Outfitters) 52-week High is $18.49, 52-week Low is: $11.572, it has supports at…
-
MA10-MA50 Bull Crossover: BCE Inc (BCE), Chimera Investment Corp (CIM), Dht Holdings (DHT), Euronav Nv (EURN), Phillips 66 Common Stock (PSX), Unitedhealth Group Inc (UNH)
NYSE: BCE (BCE Inc) NYSE: BCE (BCE Inc) has closed at $41.44, its traded Volume was 1262.81K shares, BCE opened the Day at $41.07, it made an intraday Low of $40.89, and an intraday High of $41.54. BCE (BCE Inc) 52-week High is $46.548, 52-week Low is: $31.113, it has supports at $35.33 and $31.11,…
-
Stocks Kicked Off the Week with Solid Gains
U.S. stocks closed moderately higher on Monday, as investors tried to look beyond the uncertain timing of a possible interest rate increase by the Federal Reserve. The Dow Jones Industrial Average added 125.61 points, or 0.77%, to 16,510.19. The S&P 500 gained 8.94 points, or 0.46%, to 1,966.97. The Nasdaq Composite was up 1.73 points,…
-
Stocks Rose at Open, Dow Jumped 140 Points
U.S. stocks opened higher on Monday, as investors waited for home-sales data and a speech from a key Federal Reserve member to provide further direction. The Dow Jones Industrial Average lately added 142.44 points, or 0.87%, to 16,527.02. The S&P 500 gained 14.74 points, or 0.75%, to 1,972.77. The Nasdaq Composite was up 32.34 points,…
-
Growth on Focus: AcelRx Pharmaceuticals, Inc. (ACRX)
Company Profile: AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of acute pain. The companys lead product candidate is Zalviso, an investigational, pre-programmed, non-invasive, handheld system that has completed Phase III clinical trials for the treatment of moderate-to-severe acute pain in the hospital setting. The company is also developing…
-
Momentum Stock Watch: Eaton Vance Limited Duration Income Fund (EVV)
Company Profile: Eaton Vance Limited Duration Income Fund is a closed-end investment management firm. The Fund’s investment objective is to provide a high level of current income. The Fund may, as a secondary objective, also seek capital appreciation to the extent consistent with its primary goal of high current income. The Fund invests primarily in…
Got any book recommendations?